Search Results - "nilotinib"

1

Nilotinib tedavisi sırasında iki kez iskemik serebrovasküler atak geçiren bir kronik miyeloid lösemi olgusu

by Gül İLHAN
Published 2017-09-01

Subjects: “...nilotinib...”

Get full text

Article

2

Efficacy and tolerability of treatment with line II nilotinib in a patient with coronary artery disease

by Elisa Roncoroni, Maria Luisa Pioltelli, Anna Maria Frustaci, Ester Pungolino, Enrica Morra
Published 2015-10-01

Subjects: “...Nilotinib...”

Get full text

Article

3

Nilotinib is effective and well tollerate in patients with multiple comorbidities

by Carmen Fava, Marco Fizzotti, Giuseppe Saglio, Giovanna Rege-Cambrin
Published 2015-10-01

Subjects: “...Nilotinib...”

Get full text

Article

4

Efficacy of nilotinib as third-line treatment in a patient with very late Chronic Myeloid Leukemia and a possibile cardiologic contraindication

by Ester Maria Orlandi, Sara Redaelli
Published 2015-10-01

Subjects: “...Nilotinib...”

Get full text

Article

5

Análise da viabilidade das células H295R, linhagem de carcinoma adrenocortical tumoral humano, tratadas com diferentes drogas antitumorais.

by Silveira, Elaine
Published 2014

Subjects: “...Nilotinib...”

Get full text

Others

6

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia

by E. G. Lomaia, E. G. Romanova, E. I. Sbityakova, A. Yu. Zaritskiy
Published 2014-07-01

Subjects: “...nilotinib...”

Get full text

Article

7

Faktor Risiko Musculoskeletal Pain pada Pasien Chronic Myeloid Leukemia (CML) dengan Kemoterapi Nilotinib di RSUD Dr. Moewardi

by Rasmaya Niruri, Eti Poncorini Pamungkasari, Syifa Maulida Rahmah
Published 2021-07-01

Subjects: “...nilotinib...”

Get full text

Article

8

Neuroprotective effect of nilotinib on pentylenetetrazol-induced epilepsy in adult rat hippocampus: involvement of oxidative stress, autophagy, inflammation, and apoptosis

by Ghalia Mahfouz Attia, Rasha Ahmed Elmansy, Wael M. Elsaed
Published 2019-05-01

Subjects: “...nilotinib...”

Get full text

Article

9

Treatment outcome of 100 chronic myeloid leukemia patients using nilotinib as the 2nd line therapy

by Yaseen M Taher, Ali M Almothaffar, Bassam Francis Matti, Alaa Fadhil Alwan
Published 2018-01-01

Subjects: “...nilotinib...”

Get full text

Article

10

Anticancer drugs for Parkinson's disease: Is it a ray of hope or only hype?

by Deepa Dash, Vinay Goyal
Published 2019-01-01

Subjects: “...Nilotinib...”

Get full text

Article

11

Efficacy of nilotinib in a young patient with high Sokal risk CML Ph+ in treatment failure after high dose imatinib

by Sabina Russo, Giuseppa Penna, Arianna D’Angelo, Alessandro Allegra, Andrea Alonci, Caterina Musolino
Published 2015-10-01

Subjects: “...Nilotinib...”

Get full text

Article

12

Efficacy and safety of tyrosine kinase inhibitors (dasatinib, nilotinib) in the treatment of chronic phase chronic myeloid leukemia

by E. G. Lomaia, E. G. Romanova, E. I. Sbityakova, A. Yu. Zaritskiy
Published 2014-07-01

Subjects: “...nilotinib...”

Get full text

Article

13

p53 Gene (NY-CO-13) Levels in Patients with Chronic Myeloid Leukemia: The Role of Imatinib and Nilotinib

by Hayder M. Al-kuraishy, Ali I. Al-Gareeb, Ali K. Al-Buhadilly
Published 2018-01-01

Subjects: “...nilotinib...”

Get full text

Article

14

Efficacy of nilotinib therapy in patient with CML diagnosed in pre-TKI era and resistant to imatinib

by Ivana Pierri, Micaela Bergamaschi, Antonia Cagnetta, Anna Ghiso, Marco Gobbi
Published 2015-10-01

Subjects: “...Nilotinib...”

Get full text

Article

15

Nilotinib after resistance to imatinib in CML patients with Wolf-Parkinson White syndrome

by Massimo Breccia
Published 2015-10-01

Subjects: “...Nilotinib...”

Get full text

Article

16

Deep and early molecular response induced by nilotinb in a newly diagnosed patient with chronic myeloid leukemia (CML)

by Antonella Russo Rossi
Published 2015-10-01

Subjects: “...Nilotinib...”

Get full text

Article

17

Efficacy of nilotinib in second line in an elderly patient with CML, suboptimal response and multiple comorbidities

by Carmen Tomaselli
Published 2015-10-01

Subjects: “...Nilotinib...”

Get full text

Article

18

Tyrosine Kinase Inhibitors Play an Antiviral Action in Patients Affected by Chronic Myeloid Leukemia: A Possible Model Supporting Their Use in the Fight Against SARS-CoV-2

by Sara Galimberti, Mario Petrini, Claudia Baratè, Federica Ricci, Serena Balducci, Susanna Grassi, Francesca Guerrini, Elena Ciabatti, Sandra Mechelli, Antonello Di Paolo, Chiara Baldini, Laura Baglietto, Lisa Macera, Pietro Giorgio Spezia, Fabrizio Maggi
Published 2020-09-01

Subjects: “...nilotinib...”

Get full text

Article

19